Aspirin for Preventing the Recurrence of Venous Thromboembolism
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. METHODS: In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. RESULTS: Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. CONCLUSIONS: Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding. (Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citation(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Research works printed but not linked: 2
- Schulman S, 2011, J Thromb Haemost, 9, 731
- Schulman S, 2011, J Thromb Haemost, 9, 22
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Self-citationAntithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Self-citationKonstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Self-citationOrtel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Self-citationApixaban for Extended Treatment of Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E., & Weitz, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207541 · Cited by 1,366
Self-citationNew Fundamentals in Hemostasis
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2011 · Cited by 1,126
Deep vein thrombosis and pulmonary embolism
Di Nisio, M., van Es, N., & Büller, H. R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30514-1 · Cited by 994
Antithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Lyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Kakkos, S. K., Gohel, M., Baekgaard, N., Bauersachs, R., Bellmunt-Montoya, S., Black, S. A., ten Cate-Hoek, A. J., Elalamy, I., Enzmann, F. K., Geroulakos, G., et al. (2021) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2020.09.023 · Cited by 743
Self-citationEberhardt, R. T., & Raffetto, J. D. (2014) · Circulation · doi:10.1161/circulationaha.113.006898 · Cited by 757
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700518 · Cited by 787
Self-citationO’Donnell, T. F., Passman, M. A., Marston, W. A., Ennis, W. J., Dalsing, M., Kistner, R. L., Lurie, F., Henke, P. K., Gloviczki, M. L., Eklöf, B. G., et al. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.049 · Cited by 720
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210384 · Cited by 563
Martinod, K., Demers, M., Fuchs, T. A., Wong, S. L., Brill, A., Gallant, M., Hu, J., Wang, Y., & Wagner, D. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301059110 · Cited by 532
Therapeutic strategies for thrombosis: new targets and approaches
Mackman, N., Bergmeier, W., Stouffer, G. A., & Weitz, J. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0061-0 · Cited by 388
Mazzolai, L., Aboyans, V., Ageno, W., Agnelli, G., Alatri, A., Bauersachs, R., Brekelmans, M. P. A., Büller, H. R., Elias, A., Farge, D., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx003 · Cited by 402
Self-citationManagement of venous thrombo-embolism: an update
Konstantinides, S., & Torbicki, A. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu243 · Cited by 383
The aspirin story – from willow to wonder drug
Desborough, M. J. R., & Keeling, D. M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14520 · Cited by 328
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
Streiff, M. B., Agnelli, G., Connors, J. M., Crowther, M., Eichinger, S., Lopes, R., McBane, R. D., Moll, S., & Ansell, J. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1317-0 · Cited by 344
Self-citationInflammation, Infection and Venous Thromboembolism
Colling, M. E., Tourdot, B. E., & Kanthi, Y. (2021) · Circulation Research · doi:10.1161/circresaha.121.318225 · Cited by 305
Khan, F., Rahman, A., Carrier, M., Kearon, C., Weitz, J. I., Schulman, S., Couturaud, F., Eichinger, S., Kyrle, P. A., Becattini, C., et al. (2019) · BMJ · doi:10.1136/bmj.l4363 · Cited by 328
Self-citationBecattini, C., Agnelli, G., Lankeit, M., Masotti, L., Pruszczyk, P., Casazza, F., Vanni, S., Nitti, C., Kamphuisen, P., Vedovati, M. C., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00024-2016 · Cited by 292
Self-citationDuration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
Kearon, C., & Akl, E. A. (2014) · Blood · doi:10.1182/blood-2013-12-512681 · Cited by 279
Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review
Chopard, R., Albertsen, I. E., & Piazza, G. (2020) · JAMA · doi:10.1001/jama.2020.17272 · Cited by 244
Savchenko, A. S., Martinod, K., Seidman, M. A., Wong, S. L., Borissoff, J. I., Piazza, G., Libby, P., Goldhaber, S. Z., Mitchell, R. N., & Wagner, D. D. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12571 · Cited by 269
Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration
Simes, J., Becattini, C., Agnelli, G., Eikelboom, J. W., Kirby, A. C., Mister, R., Prandoni, P., & Brighton, T. A. (2014) · Circulation · doi:10.1161/circulationaha.114.008828 · Cited by 262
Self-citationLafarga, T., Acién-Fernández, F. G., & Garcia-Vaquero, M. (2020) · Algal Research · doi:10.1016/j.algal.2020.101909 · Cited by 246
Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
Yeung, J., Li, W., & Holinstat, M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014530 · Cited by 242
Couturaud, F., Sanchez, O., Pernod, G., Mismetti, P., Jego, P., Duhamel, E., Provost, K., dit Sollier, C. B., Presles, E., Castellant, P., et al. (2015) · JAMA · doi:10.1001/jama.2015.7046 · Cited by 249
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences
Mezouar, S., Frère, C., Darbousset, R., Mege, D., Crescence, L., Dignat-George, F., Panicot-Dubois, L., & Dubois, C. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.01.006 · Cited by 218
Arnaud, L., Mathian, A., Ruffatti, A., Erkan, D., Tektonidou, M., Cervera, R., Forastiero, R., Pengo, V., Lambert, M., Martinez-Zamora, M. A., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.014 · Cited by 215
The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation
Rayes, J., Bourne, J. H., Brill, A., & Watson, S. P. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12266 · Cited by 185
Statins as Antithrombotic Drugs
Violi, F., Calvieri, C., Ferro, D., & Pignatelli, P. (2013) · Circulation · doi:10.1161/circulationaha.112.145334 · Cited by 205
Sterne, J. A., Bodalia, P. N., Bryden, P. A., Davies, P. A., López-López, J. A., Okoli, G. N., Thom, H. H., Caldwell, D. M., Dias, S., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21090 · Cited by 198
Hydrogen Peroxide Promotes Aging-Related Platelet Hyperactivation and Thrombosis
Dayal, S., Wilson, K. M., Motto, D. G., Miller, F. J., Chauhan, A. K., & Lentz, S. R. (2013) · Circulation · doi:10.1161/circulationaha.112.000966 · Cited by 192
Castellucci, L. A., Cameron, C., Le Gal, G., Rodger, M. A., Coyle, D., Wells, P. S., Clifford, T., Gandara, E., Wells, G., & Carrier, M. (2013) · BMJ · doi:10.1136/bmj.f5133 · Cited by 193
Nicolaides, A., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., Myers, K., Samama, M., Fletcher, J., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840 · Cited by 185
Self-citationImmunothrombosis and thromboinflammation in host defense and disease
Martinod, K., & Deppermann, C. (2020) · Platelets · doi:10.1080/09537104.2020.1817360 · Cited by 165
Development and use of sulodexide in vascular diseases: implications for treatment
COCCHERI, S., & Mannello, F. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s6762 · Cited by 161
Essential thrombocythemia treatment algorithm 2018
Tefferi, A., Vannucchi, A. M., & Barbui, T. (2018) · Blood Cancer Journal · doi:10.1038/s41408-017-0041-8 · Cited by 146
Creager, M. A., Barnes, G. D., Giri, J., Mukherjee, D., Jones, W. S., Burnett, A. E., Carman, T., Casanegra, A. I., Castellucci, L. A., Clark, S. M., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001415 · Cited by 250
Mazzolai, L., Ageno, W., Alatri, A., Bauersachs, R. M., Becattini, C., Brodmann, M., Emmerich, J., Konstantinides, S., Meyer, G., Middeldorp, S., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab088 · Cited by 153
Self-citationEpidemiology of venous thromboembolism in the Framingham Heart Study
Puurunen, M. K., Gona, P. N., Larson, M. G., Murabito, J. M., Magnani, J. W., & O’Donnell, C. J. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.06.033 · Cited by 148
Creager, M. A., Barnes, G. D., Giri, J., Mukherjee, D., Jones, W. S., Burnett, A. E., Carman, T., Casanegra, A. I., Castellucci, L. A., Clark, S. M., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.11.005 · Cited by 143
Diagnosis and management of pulmonary embolism
Lapner, S. T., & Kearon, C. (2013) · BMJ · doi:10.1136/bmj.f757 · Cited by 133
Andreozzi, G. M., Bignamini, A. A., Davì, G., Palareti, G., Matuška, J., Holý, M., Pawlaczyk-Gabriel, K., Džupina, A., Юрьевич, С. Г., Didenko, Y. P., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016930 · Cited by 131
Pulmonary embolism: risk assessment and management
Konstantinides, S., & Goldhaber, S. Z. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs258 · Cited by 130
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
Yeh, C. H., Gross, P. L., & Weitz, J. I. (2014) · Blood · doi:10.1182/blood-2014-03-563056 · Cited by 136
Pérez‐Sánchez, C., Ruiz‐Limón, P., Aguirre, M. A., Jiménez, Y., de la Rosa, I. A., Ábalos‐Aguilera, M. C., Rodríguez‐Ariza, A., Castro, C., Castro, R. O., Segui, P., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.04.007 · Cited by 126
The history and historical treatments of deep vein thrombosis
Galanaud, J. ‐., Laroche, J.-P., & Righini, M. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12127 · Cited by 124
Olaf, M. F., & Cooney, R. R. (2017) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2017.06.003 · Cited by 138
Antithrombotic Agents: New Directions in Antithrombotic Therapy
Chan, N., & Weitz, J. I. (2019) · Circulation Research · doi:10.1161/circresaha.118.313155 · Cited by 120
Azboy, İ., Barrack, R. L., Thomas, A. M. C., Haddad, F. S., & Parvizi, J. (2017) · The Bone & Joint Journal · doi:10.1302/0301-620x.99b11.bjj-2017-0337.r2 · Cited by 121
Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus
Seliverstov, E. I., Lobastov, K. V., Ilyukhin, Е. А., Apkhanova, T. V., Akhmetzyanov, R. V., Akhtyamov, I. F., Barinov, V., Bakhmetiev, A. S., Belov, M. V., Александрович, Б. С., et al. (2023) · Journal of Venous Disorders · doi:10.17116/flebo202317031152 · Cited by 121
Thrombosis in pregnancy: updates in diagnosis and management
Greer, I. A. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.203.3798262 · Cited by 110
Ho, K. M., Bham, E., & Pavey, W. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002652 · Cited by 108
Acute pulmonary embolism: a concise review of diagnosis and management
Rayner, M., Darvall, J. N., & Hammerschlag, G. (2018) · Internal Medicine Journal · doi:10.1111/imj.14145 · Cited by 109
Translational Implications of Platelets as Vascular First Responders
Becker, R. C., Sexton, T. R., & Smyth, S. S. (2018) · Circulation Research · doi:10.1161/circresaha.117.310939 · Cited by 107
Sutcliffe, P. A., Connock, M. J., Gurung, T., Freeman, K., Johnson, S. A., Kandala, N., Grove, A., Gurung, B., Morrow, S., & Clarke, A. (2013) · Health Technology Assessment · doi:10.3310/hta17430 · Cited by 111
Platelets in cancer and thrombosis
Riedl, J., Pabinger, I., & Ay, C. (2013) · Hämostaseologie · doi:10.5482/hamo-13-10-0054 · Cited by 108
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia
Patrono, C., Rocca, B., & Stefano, V. D. (2013) · Blood · doi:10.1182/blood-2012-10-429134 · Cited by 104
Undas, A., Brummel‐Ziedins, K. E., & Mann, K. G. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12728 · Cited by 99
Platelets are dominant contributors to hypercoagulability after injury
Harr, J. N., Moore, E. E., Chin, T. L., Ghasabyan, A., González, E., Wohlauer, M. V., Banerjee, A. M., Silliman, C. C., & Sauaia, A. (2013) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182826d7e · Cited by 96
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study
Cieślik, J., Mrozińska, S., Broniatowska, E., & Undas, A. (2017) · Blood · doi:10.1182/blood-2017-07-798306 · Cited by 96
Klemen, N. D., Feingold, P. L., Hashimoto, B., Wang, M., Kleyman, S., Brackett, A. L., Gross, C. P., & Pei, K. Y. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30211-8 · Cited by 96
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
Sharma, S. H., Tyagi, T., & Antoniak, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039843 · Cited by 94
Cuadrado, M. J., Bertolaccini, M. L., Seed, P. T., Tektonidou, M. G., Aguirre, A., Micó, L., Gordon, C., Ruiz‐Irastorza, G., Egurbide, M.-V., Gil, A., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket313 · Cited by 101
D’Alessandro, E., Becker, C., Bergmeier, W., Bode, C., Bourne, J. H., Brown, H. C., Buller, H. R., ten Cate‐Hoek, A. J., ten Cate, V., van Cauteren, Y. J. M., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1708035 · Cited by 99
Gianesini, S., Obi, A. T., Onida, S., Baccellieri, D., Bissacco, D., Борсук, Д. А., Campisi, C., Campisi, C. C., Cavezzi, A., Chi, Y., et al. (2019) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355519870690 · Cited by 99
Lydiatt, W. M., Bessette, D., Schmid, K. K., Sayles, H. R., & Burke, W. J. (2013) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2013.3371 · Cited by 87
Update on the management of venous thromboembolism
Bartholomew, J. R. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s3.04 · Cited by 85
Venous Thromboembolism Following Hip and Knee Arthroplasty: The Role of Aspirin
Parvizi, J., Ceylan, H. H., Küçükdurmaz, F., Merli, G. J., Tuncay, İ., & Beverland, D. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.01253 · Cited by 83
Mekaj, A., Mekaj, Y., & Daci, F. T. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s92222 · Cited by 83
O’Donnell, T. F., & Passman, M. A. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.058 · Cited by 82
Uresandi, F., Monréal, M., García-Bragado, F., Domenech, P., Lecumberri, R., Escribano, P., Zamorano, J. L., Jiménez, S., Ruiz‐Artacho, P., Lozano, F., et al. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2013.07.008 · Cited by 80
Bode, C., Ahrens, I., & Duerschmied, D. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-02-0146 · Cited by 87
Beam, D. M., Kahler, Z. P., & Kline, J. A. (2015) · Academic Emergency Medicine · doi:10.1111/acem.12711 · Cited by 73
Starikova, I., Jamaly, S., Sorrentino, A., Blöndal, T., Latysheva, N., Sovershaev, M. A., & Hansen, J. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.07.005 · Cited by 73
Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study
Ho, K. M., Yip, C. B., & Duff, O. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04846.x · Cited by 70
Kessinger, C. W., Kim, J. W., Henke, P. K., Thompson, B. D., McCarthy, J. R., Hara, T., Sillesen, M., Margey, R., Libby, P., Weissleder, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116621 · Cited by 70
Medjeral‐Thomas, N., Ziaj, S., Condon, M. B., Galliford, J. W., Levy, J. B., Cairns, T. D. H., & Griffith, M. E. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07190713 · Cited by 68
Cohen, A. T., Hamilton, M., Bird, A., Mitchell, S. A., Li, S., Horblyuk, R. V., & Batson, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160064 · Cited by 74
Khamashta, M. A., Taraborelli, M., Sciascia, S., & Tincani, A. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.04.002 · Cited by 81
Platelet–Neutrophil Crosstalk in Thrombosis
Mereweather, L. J., Constantinescu‐Bercu, A., Crawley, J. T. B., & Salles, I. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021266 · Cited by 65
Assessing the risk of recurrent venous thromboembolism – a practical approach
Keo, H. H., Fahrni, J., Husmann, M. J. W., & Gretener, S. B. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s83718 · Cited by 81
Statins Effects on Blood Clotting: A Review
Siniscalchi, C., Basaglia, M., Riva, M. A., Meschi, M., Meschi, T., Castaldo, G., & Micco, P. D. (2023) · Cells · doi:10.3390/cells12232719 · Cited by 62
Extended treatment of venous thromboembolism: a systematic review and network meta-analysis
Wang, K.-L., van Es, N., Cameron, C. G., Castellucci, L. A., Buller, H. R., & Carrier, M. (2018) · Heart · doi:10.1136/heartjnl-2018-313617 · Cited by 61
Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
Heestermans, M., Poénou, G., Duchez, A., Hamzeh‐Cognasse, H., Bertoletti, L., & Cognasse, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113176 · Cited by 61
Platelets and Cancer-Associated Thrombosis
Connolly, G. C., Phipps, R. P., & Francis, C. W. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.04.009 · Cited by 60
Is diabetes a hypercoagulable state? A critical appraisal
Pomero, F., Minno, M. N. D. D., Fenoglio, L. M., Gianni, M., Ageno, W., & Dentali, F. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0746-8 · Cited by 59
Self-citationStark, K., Schubert, I., Joshi, U., Kilani, B., Hoseinpour, P., Thakur, M., Grünauer, P., Pfeiler, S., Schmidergall, T., Stockhausen, S., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310262 · Cited by 58
Tarantino, E., Amadio, P., Squellerio, I., Porro, B., Sandrini, L., Turnu, L., Cavalca, V., Tremoli, E., & Barbieri, S. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.001 · Cited by 57
Aspirin for Dual Prevention of Venous and Arterial Thrombosis
Warkentin, T. E. (2012) · New England Journal of Medicine · doi:10.1056/nejme1211480 · Cited by 56
Antithrombotic Management of Venous Thromboembolism
Renner, E., & Barnes, G. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.070 · Cited by 59
Piazza, G. (2013) · JAMA · doi:10.1001/jama.2012.164493 · Cited by 55
Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
Filho, A. M. L., Azmus, A., Soeiro, A., Quadros, A., Avezum, Á., Marques, A., Franci, A., Manica, A., Volschan, A., de Paola, A., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s009 · Cited by 95
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
Tefferi, A., & Barbui, T. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.014 · Cited by 59
Metadata
- Authors
- Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., Grandone, E., & Prandoni, P.
- Affiliations
- University of Perugia (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Medical University of Vienna (AT)
- Ospedale per gli Infermi (IT)
- Santa Maria Nuova Hospital (IT)
- Ospedale Valduce (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Insubria (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Padua (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1959-1967
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975990989
- Cited by
- 620
- References
- 37
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 11 · 2022: 23 · 2021: 39 · 2020: 40 · 2019: 34 · 2018: 45 · 2017: 53 · 2016: 52 · 2015: 75 · 2014: 69 · 2013: 90 · 2012: 33
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Bayer HealthCare
- Università degli Studi di Perugia
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, major bleeding, secondary prevention, anticoagulation
- MeSH terms
- Aged, Anticoagulants, Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pulmonary Embolism, Vitamin K, Venous Thrombosis, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.